Tag: NIH
-
NIH Grant Funds New Spinal Cord Injury Treatment
A biotechnology company developing regenerative therapies for neurological disorders is receiving a Small Business Innovation Research grant to advance an experimental treatment for spinal cord injury.
-
Engineered Polio Virus Tested as Brain Cancer Treatment
Results of a clinical trial show a genetically engineered polio virus helps more people with glioblastoma, an aggressive form of brain cancer, survive for longer periods.
-
Univ. Spin-Off Developing Long-Lasting Diabetes Drug
A company spun-off from a University at Buffalo biochemistry lab is the recipient of a small business grant to design a once-a-week drug for people with type 2 diabetes to control their blood sugar and weight.
-
$3.4M NIH Grant Funding New ALS Treatments
A biotechnology company is receiving a grant from National Institute of Neurological Disorders and Stroke to advance its experimental treatments for amyotrophic lateral sclerosis, or ALS.
-
NIH, Biotech Partner on Electro-Aided Crispr for Sickle Cell
The National Heart, Lung, and Blood Institute and a biotechnology company are testing genome editing with electronically treated cells as a therapy for sickle cell disease.
-
Single Technology Produces Vaccines for Multiple Infectious Diseases
A single technology platform is being used to design and produce vaccines that in tests with lab animals protect against a number of infectious diseases.
-
Data Tools Designed for Genomics-Based Precision Cancer Care
A computerized system is available that analyzes the genomic composition of cancer patients and recommends personalized treatments that its designers say take into account a larger array of factors than comparable systems.
-
Univ. Spinoff Qualifies for NIH Clinical Program
An enterprise developing a synthetic antibody to treat breast cancer, spun-off from a University at Buffalo research lab, is taking part in a federal program to advance the treatments to clinical trials.
-
Trial Underway Testing Universal Flu Vaccine
A clinical trial is recruiting participants to test a vaccine to protect against a variety of influenza strains, instead of today’s vaccines designed to prevent infections from specific strains expected in a given year.
-
Global Health R&D Cuts Threaten U.S. Economy, Jobs
An analysis of the impact of proposed cuts in funds for research and development on technologies to address global health needs shows the U.S. economy benefits directly from this spending, including support of many jobs in nearly all states.